These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2289857)

  • 1. [What is guaranteed in the therapy of primary biliary cirrhosis with bile acids?].
    Leuschner U
    Internist (Berl); 1990 Nov; 31(11):707-11. PubMed ID: 2289857
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of primary biliary cirrhosis with ursodeoxycholic acid without liver biopsy?].
    Siboni AH
    Ugeskr Laeger; 2004 Aug; 166(32):2688; author reply 2688. PubMed ID: 15347178
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of primary biliary cirrhosis with ursodeoxycholic acid].
    Lotterer E; Fleig WE
    Z Gastroenterol; 1993 Oct; 31(10):633-5. PubMed ID: 8256481
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
    Raedsch R; Stiehl A; Hopf U; Möller B
    Z Gastroenterol Verh; 1989 Jul; 24():125-7. PubMed ID: 2474923
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bronchiolitis obliterans with organizing pneumonia and primary biliary cirrhosis].
    Montero C; Brage A; Rodríguez-Trigo G; Verea H
    Med Clin (Barc); 2003 Jan; 120(1):37-8. PubMed ID: 12525305
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis.
    Batta AK; Salen G; Mirchandani R; Tint GS; Shefer S; Batta M; Abroon J; O'Brien CB; Senior JR
    Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid for chronic liver diseases.
    Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
    J Clin Gastroenterol; 1988; 10 Suppl 2():S25-31. PubMed ID: 3062082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study].
    Leuschner U; Fischer H; Hübner K
    Z Gastroenterol Verh; 1989 Jul; 24():133. PubMed ID: 2474926
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ursodeoxycholic acid in primary biliary cirrhosis. 2: Prospective long-term study of 21 patients].
    Eisenburg J; Eder M; Spengler U; Berg PA; Caselmann W; Mannes AG; Muntau A
    Fortschr Med; 1988 Nov; 106(34):695-8. PubMed ID: 3145247
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary biliary cirrhosis. Immunological aggression and aggression by biliary acids].
    Poupon R
    Rev Prat; 1994 May; 44(10):1325-8. PubMed ID: 7939192
    [No Abstract]   [Full Text] [Related]  

  • 13. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic trials in primary biliary cirrhosis.
    Sherlock S
    QJM; 1994 Nov; 87(11):701-3. PubMed ID: 7820545
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinophils and primary biliary cirrhosis-stoking the fire?
    Neuberger J
    Hepatology; 1999 Jul; 30(1):335-7. PubMed ID: 10385676
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid.
    Renou C; Bourlière M; Martini F; Ouzan D; Penaranda G; Larroque O; Harafa A; Igual JP; Calvet B; Sokolowsky S; Benderitter T; Halfon P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):781-2. PubMed ID: 16677173
    [No Abstract]   [Full Text] [Related]  

  • 17. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis.
    Leevy CB; Holt J; Buniak B
    J Assoc Acad Minor Phys; 1993; 4(1):30-2. PubMed ID: 8425102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholate in primary biliary cirrhosis any--different from the rest?
    Janardan SK; Moseley RH
    J Clin Gastroenterol; 1994 Jan; 18(1):2-3. PubMed ID: 8113579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.